Arabic Arabic English English French French German German
dark

Diadem Announces Publication of Clinical Data Showing Its AlzoSure® Biomarker Test Accurately Predicts Progression to Alzheimer’s Disease Six Years Before Diagnosis

Diadem srl, a company developing the first blood-based test for the early prediction of progression to Alzheimer’s disease, announced results from a retrospective longitudinal study of its AlzoSure® Predict prognostic biomarker test. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Lilly and Lycia Ink $1.6 Billion+ Collaboration and Licensing Deal

Next Post

PharmaBlock Announces the Appointment of Dr. Xudong Wei as Senior Vice President to Lead and Enhance Small Molecule CDMO Services

Related Posts
Total
0
Share